Similar articles

• Successful treatment of vitiligo with 0.1% tacrolimus ointment.

  Travis LB, Weinberg JM, Silverberg NB. Travis LB, et al. Arch Dermatol. 2003 May;139(5):571-4; discussion 573. doi: 10.1001/archderm.139.5.571. Arch Dermatol. 2003. PMID: 12756092 No abstract available.
• Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo.

  Sehgal VN. Sehgal VN. J Eur Acad Dermatol Venereol. 2009 Oct;23(10):1218-9. doi: 10.1111/j.1468-3083.2009.03128.x. Epub 2009 Mar 3. J Eur Acad Dermatol Venereol. 2009. PMID: 19192018 No abstract available.
• Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment.

  Wilson LM, Reid CM. Wilson LM, et al. Australas J Dermatol. 2004 Aug;45(3):184-5. doi: 10.1111/j.1440-0960.2004.00086.x. Australas J Dermatol. 2004. PMID: 15250900
• Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus.

  Lerbaek A, Agner T. Lerbaek A, et al. Br J Dermatol. 2004 Jun;150(6):1210-1. doi: 10.1111/j.1365-2133.2004.06008.x. Br J Dermatol. 2004. PMID: 15214914 Review. No abstract available.
• Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.

  Sisti A, Sisti G, Oranges CM. Sisti A, et al. An Bras Dermatol. 2016 Apr;91(2):187-95. doi: 10.1590/abd1806-4841.20164012. An Bras Dermatol. 2016. PMID: 27192518 Free PMC article. Review.